{{Rsnum
|rsid=1556459
|Chromosome=10
|position=130810711
|Orientation=plus
|GMAF=0.2176
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.4 | 24.8 | 70.8
| HCB | 1.5 | 27.0 | 71.5
| JPT | 5.3 | 34.5 | 60.2
| YRI | 17.0 | 48.3 | 34.7
| ASW | 14.0 | 36.8 | 49.1
| CHB | 1.5 | 27.0 | 71.5
| CHD | 2.8 | 30.3 | 67.0
| GIH | 1.0 | 22.8 | 76.2
| LWK | 19.1 | 44.5 | 36.4
| MEX | 3.4 | 29.3 | 67.2
| MKK | 8.3 | 46.2 | 45.5
| TSI | 1.0 | 14.7 | 84.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=22258532
|Title=A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}